abstract |
The present invention relates to a composition comprising a nicotinic receptor agonist and method for preventing and treating inflammatory diseases related to body inflammation including arthritis, cutaneous inflammation and cardio-vascular inflammatory related diseases. Particular nicotinic receptor agonist disclosed for the treatment and prevention of arthritis, cutaneous inflamation and cardiovascular inflamatory related diseases include dimethylphenylpiperazinium (DMPP), nicotine, epibatidine, cytisine, mecamylamine, acetylcholine, pyridlethers, tubocurarine, trimethaphan, hexamethonium, N-methylcaramylcholine, ABT-418, GTS-21, MLA, DHβE, Arecoline, lobeline, philanthotoxin-433, azabicyclin, SIB-1553, and imidacloprit. |